Could GLP-1s Help Endometriosis? The Progesterone Resistance Theory

Could GLP-1s Help Endometriosis? The Progesterone Resistance Theory

From The Dr. Brighten Show by Dr. Jolene Brighten

April 28, 2026 · 28 min · Season 1 · Episode 135

About this episode

Dr. Brighten explores the potential of GLP-1 medications in addressing progesterone resistance in endometriosis.

Can a GLP-1 medication change the way progesterone works in endometriosis? That is the central question Dr. Brighten explores in this episode, and it is not a throwaway idea. It sits at the intersection of inflammation, hormone receptor signaling, and the reality that many women are told to manage endometriosis with options that reduce symptoms without stopping the disease process. This episode examines a novel mechanistic theory: GLP-1 agonists may help restore progesterone responsiveness by lowering inflammatory signaling inside endometriosis lesions. The conversation is careful about the evidence stage. The research is promising, but it is still emerging, and the episode makes that distinction clear while still taking women’s lived experience seriously. That matters because women with endometriosis are often told to accept unbearable pain, mood changes, and gut disruption as normal. This episode does not accept that as the end of the story. It asks a better question: what if the inflammatory environment is part of why progesterone stops working the way it should? This episode changes the conversation. This Episode Is Brought to You By Dr. Brighten Essentials Want…

People in this episode

Host: Dr. Jolene Brighten

Topics covered

  • GLP-1 medications
  • endometriosis
  • progesterone resistance
  • inflammation
  • hormone receptor signaling

Keywords

  • GLP-1
  • endometriosis
  • progesterone
  • inflammation
  • hormone signaling
  • pain management
  • women's health

Sponsors

Dr. Brighten Essentials

More episodes of The Dr. Brighten Show

Explore listener stats, chart rankings, contacts and more on the The Dr. Brighten Show podcast page.